<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="4027">Cyclophosphamide</z:chebi> is an <z:chebi fb="1" ids="35705">immunosuppressive agent</z:chebi> and an anticancer <z:chebi fb="0" ids="50266">prodrug</z:chebi> which requires bioactivation catalyzed primarily by <z:chebi fb="0" ids="38559">cytochrome P450</z:chebi> enzymes in order to be transformed into its active alkylating compounds </plain></SENT>
<SENT sid="1" pm="."><plain>Concomitant administration of drugs known to inhibit or induce this enzyme system is a clinical concern </plain></SENT>
<SENT sid="2" pm="."><plain>Herein, we present the case of a <z:e sem="disease" ids="C0008715" disease_type="Disease or Syndrome" abbrv="">chronically ill</z:e> 21-year-old patient who received high-dose <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, equine antithymocyte globulin (eATG), and total body irradiation (TBI) followed by an allogeneic hematopoietic stem cell transplant (HSCT) for severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Throughout her hospitalization, she continued to receive quadruple <z:chebi fb="0" ids="35623">anticonvulsant</z:chebi> therapy including <z:chebi fb="1" ids="8069">phenobarbital</z:chebi> for her long-standing <z:hpo ids='HP_0001250'>seizure</z:hpo> history </plain></SENT>
<SENT sid="4" pm="."><plain>The preparative regimen was tolerated well aside from a hypersensitivity reaction to eATG, and minimal <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>-related toxicities </plain></SENT>
<SENT sid="5" pm="."><plain>Safe and effective administration of high-dose <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> was possible with multidisciplinary care consisting of physician, nursing, pharmacy, neurology consultation, as well as social work and case management </plain></SENT>
</text></document>